REMEGEN CO., LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.25 HKD | +0.16% |
|
+4.00% | -16.69% |
| 26/04 | RemeGen Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04/04 | Remegen Gets US FDA Fast Track Designation for Primary Sjögren's Syndrome Medication | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| REMEGEN CO., LTD. | Bio Therapeutic Drugs | +0.16% | +4.00% | -16.69% | -20.91% | - | 3.49B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- 9995 Stock
- Charts RemeGen Co., Ltd.
- Comparison Chart